Drug companies pledge to provide cheap cervical cancer vaccine to poor nationsNovember 14th, 2007 - 1:54 am ICT by admin
At a conference organised by the UN Development Fund for Women in Brussels, Belgium, last week, one of the companies, Merck, pledged to give enough vaccine to treat a million women in the poorest countries over the next five years.
A course of vaccine against the human papillomavirus (HPV), the cause of the majority of cases, is about 360 dollars in the US, reports New Scientist.
Out of the 250,000 women killed by cervical cancer annually, 80 per cent belong to poor nations. In developed countries, the screening to catch the cancer early has cut death rates.
The conference urged participants to develop more screening techniques in poor nations.
HPV is a sexually transmitted infection, and so the vaccine is targeted at young girls who are not yet sexually active. (ANI)
- Vaccination can prevent cervical cancer deaths: Experts - Aug 07, 2012
- HPV vaccine also works for boys: Study - Feb 05, 2011
- Only one-third of young US girls receive HPV vaccine for cervical cancer - Jun 02, 2010
- Shot for preventing genital warts works in men - Feb 06, 2011
- Early sex cause of cervical cancer among poor women - Jan 02, 2010
- Early sex 'doubles cervical cancer risk' - Dec 22, 2009
- Screening can save Indian women from killer cancer - Mar 06, 2011
- BBC documentary to tackle oral sex cancer risk - Oct 17, 2010
- Mums play key role in convincing daughters to receive HPV vaccine - Jan 04, 2011
- Oral sex, HPV puts non-smoking US men at highest risk for oral cancer - Apr 19, 2011
- Jab-free HPV vaccine 'more effective, cheaper' for developing nations - Nov 18, 2010
- 'HPV testing should be the primary screening method for cervical cancer' - Apr 28, 2010
- Cervical cancer leading cancer-killer among Indian women - Mar 28, 2012
- Circumcision Lowers HPV Risk In Women, Says Survey - Jan 08, 2011
- Harnessing Technology to Empower Women - Jun 10, 2010
Tags: 360, brussels belgium, cancer rates, cervical cancer vaccine, conference organised, death rates, developed countries, development fund, drug companies, human papillomavirus hpv, merck, new scientist, poor countries, poor nations, poorest countries, screening techniques, sexually active, sexually transmitted infection, urged participants